Every resident learns to convert opioids from a table. Somewhere on your badge, in an app, or taped inside a workroom cabinet, there is a grid of morphine equivalents you reach for when a patient rotates from one agent to another. The table is useful. It is also one of the most quietly dangerous documents in medicine, because it looks like an answer when it is only a starting point.
Here is what the table does not tell you.
The numbers come from patients who are not yours
Most equianalgesic ratios trace back to single-dose studies, many of them conducted decades ago in opioid-naive patients or in acute, controlled settings. That is a reasonable way to estimate relative potency for a first exposure. It is a poor way to predict what happens in a patient who has been on chronic oxycodone for eight months.
Chronic exposure changes the picture. Tolerance, receptor adaptation, active metabolites, and individual pharmacogenetics all shift the real-world ratio away from the tidy number in the grid. The table gives you a population average for a situation that may not resemble the patient in front of you. Treat the output as a hypothesis to test, not a dose to sign.
Cross-tolerance is incomplete, and that cuts against you
When a patient is tolerant to one opioid, they are only partially tolerant to the next. The receptors have adapted to the drug they have been seeing, not to the one you are rotating them to. This is incomplete cross-tolerance, and it is the single most important safety concept in opioid rotation.
The practical consequence: if you convert at the full calculated equianalgesic dose, you can overshoot. The new drug hits harder than the math predicted, because the patient's tolerance does not fully transfer. Standard practice is to reduce the calculated dose by 25 to 50 percent, then titrate to effect. The reduction is not conservatism for its own sake; it is a correction for a known gap between the table and the receptor.
How much to reduce depends on the clinical picture. A frail, elderly, or medically complex patient sits at the larger end of that reduction. A younger patient with severe, poorly controlled pain and good organ function may need less. The point is that the reduction is a decision, not a default, and it belongs to you rather than the calculator.
Methadone breaks the math entirely
Everything above assumes the conversion is roughly linear; that is, doubling the dose of drug A means roughly doubling the equivalent of drug B. Methadone does not obey that assumption, and this is where table-driven conversions cause real harm.
Methadone's conversion ratio is not fixed. It steepens as the total daily morphine-equivalent dose climbs. A patient on a modest opioid dose might convert at one ratio; a patient on a high dose converts at a substantially different, higher ratio. A single equianalgesic number cannot capture a relationship that changes with the dose itself. Any table that gives you one methadone ratio is, by design, wrong across most of the range.
Layer on the pharmacology. Methadone has a long and variable half-life, which can extend well beyond its duration of analgesia. That mismatch means a patient can feel comfortable on day one and accumulate the drug to a dangerous level by day three, after you have stopped watching closely. Methadone also carries NMDA-receptor activity and QT-prolongation risk that other opioids do not. The result is a drug where a linear table becomes a setup for delayed, sometimes fatal, overdose.
The takeaway is not that methadone is untouchable. It is an excellent analgesic in the right hands. The takeaway is that methadone conversion is a specialist conversation, not a calculation. Involve palliative care or pain management, use conservative and often protocol-specific approaches, and do not let a calculator hand you a single number and a false sense of safety.
What good practice looks like
A safe opioid rotation follows a short discipline that no table encodes on its own.
Start with an accurate total daily dose of the current opioid, including breakthrough. Calculate the equianalgesic dose of the target opioid as a starting estimate. Reduce that estimate by 25 to 50 percent for incomplete cross-tolerance, weighted by how frail or high-risk the patient is. Provide adequate breakthrough dosing and reassess early, because titration to effect is where the real dose is found. For methadone, step out of the arithmetic entirely and bring in specialist guidance.
None of this is exotic. It is the difference between using a tool and trusting it blindly.
Why we built the calculator to refuse
We designed the
DUK-C opioid conversion calculator around one principle: a clinical tool should be honest about its own limits. For routine rotations, it does the arithmetic and shows the cross-tolerance reduction so the starting range is explicit. For methadone, it does not hand you a number. It flags the conversion as high-risk and points you toward specialist input, because a number in that box would be a number we could not stand behind.
That refusal is the feature. The math is a starting point; the judgment is yours.
The clinical protocols on DUK-C are free. Try the conversion calculator and the full protocol library at dukc.app.